Article: Erratum: Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response (Investigational New Drugs DOI: 10.1007/s10637-009-9316-7)

File Download

ft.pdf

Links for fulltext
(May Require Subscription)

Publisher Website: 10.1007/s10637-010-9397-3
Scopus: eid_2-s2.0-77952237521

Supplementary

Citations:
- Scopus:
- Web of Science:
- PubMed Central:
Item Statistics (The Hub)
Appears in Collections:
- Microbiology: Journal/Magazine Articles
- Springer Open Choice

Title	Erratum: Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response (Investigational New Drugs DOI: 10.1007/s10637-009-9316-7)
Authors	Ma, BBY2 3 Lui, VWY3 Poon, FF3 Wong, SCC3 To, KF2 Wong, E3 Chen, H1 Lo, KW3 Tao, Q3 Ng, MHL2 Cheng, SH2 Chan, ATC3
Issue Date	2010
Publisher	Springer New York LLC. The Journal's web site is located at http://springerlink.metapress.com/openurl.asp?genre=journal&issn=0167-6997
Citation	Investigational New Drugs, 2010, v. 28 n. 3, p. 361 [How to Cite?] DOI: http://dx.doi.org/10.1007/s10637-010-9397-3
ISSN	0167-6997 2011 Impact Factor: 3.357 2011 SCImago Journal Rankings: 0.223
DOI	http://dx.doi.org/10.1007/s10637-010-9397-3

DC Field	Value
dc.contributor.author	Ma, BBY
dc.contributor.author	Lui, VWY
dc.contributor.author	Poon, FF
dc.contributor.author	Wong, SCC
dc.contributor.author	To, KF
dc.contributor.author	Wong, E
dc.contributor.author	Chen, H
dc.contributor.author	Lo, KW
dc.contributor.author	Tao, Q
dc.contributor.author	Ng, MHL
dc.contributor.author	Cheng, SH
dc.contributor.author	Chan, ATC
dc.date.accessioned	2010-10-19T04:34:38Z
dc.date.available	2010-10-19T04:34:38Z
dc.date.issued	2010
dc.description.nature	published_or_final_version
dc.description.other	Springer Open Choice, 01 Dec 2010
dc.identifier.citation	Investigational New Drugs, 2010, v. 28 n. 3, p. 361 [How to Cite?] DOI: http://dx.doi.org/10.1007/s10637-010-9397-3
dc.identifier.citeulike	6804307
dc.identifier.doi	http://dx.doi.org/10.1007/s10637-010-9397-3
dc.identifier.eissn	1573-0646
dc.identifier.epage	361
dc.identifier.issn	0167-6997 2011 Impact Factor: 3.357 2011 SCImago Journal Rankings: 0.223
dc.identifier.issue	3
dc.identifier.scopus	eid_2-s2.0-77952237521
dc.identifier.spage	361
dc.identifier.uri	http://hdl.handle.net/10722/124033
dc.identifier.volume	28
dc.language	Eng
dc.publisher	Springer New York LLC. The Journal's web site is located at http://springerlink.metapress.com/openurl.asp?genre=journal&issn=0167-6997
dc.publisher.place	United States
dc.relation.ispartof	Investigational New Drugs
dc.rights	Springer Science+Business Media, LLC
dc.rights	Creative Commons: Attribution 3.0 Hong Kong License
dc.title	Erratum: Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response (Investigational New Drugs DOI: 10.1007/s10637-009-9316-7)
dc.type	Article

<?xml encoding="utf-8" version="1.0"?><item><contributor.author>Ma, BBY</contributor.author><contributor.author>Lui, VWY</contributor.author><contributor.author>Poon, FF</contributor.author><contributor.author>Wong, SCC</contributor.author><contributor.author>To, KF</contributor.author><contributor.author>Wong, E</contributor.author><contributor.author>Chen, H</contributor.author><contributor.author>Lo, KW</contributor.author><contributor.author>Tao, Q</contributor.author><contributor.author>Ng, MHL</contributor.author><contributor.author>Cheng, SH</contributor.author><contributor.author>Chan, ATC</contributor.author><date.accessioned>2010-10-19T04:34:38Z</date.accessioned><date.available>2010-10-19T04:34:38Z</date.available><date.issued>2010</date.issued><identifier.citation>Investigational New Drugs, 2010, v. 28 n. 3, p. 361</identifier.citation><identifier.issn>0167-6997</identifier.issn><identifier.uri>http://hdl.handle.net/10722/124033</identifier.uri><language>Eng</language><publisher>Springer New York LLC. The Journal&apos;s web site is located at http://springerlink.metapress.com/openurl.asp?genre=journal&amp;issn=0167-6997</publisher><relation.ispartof>Investigational New Drugs</relation.ispartof><rights>Springer Science+Business Media, LLC</rights><rights>Creative Commons: Attribution 3.0 Hong Kong License</rights><title>Erratum: Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response (Investigational New Drugs DOI: 10.1007/s10637-009-9316-7)</title><type>Article</type><description.nature>published_or_final_version</description.nature><identifier.doi>10.1007/s10637-010-9397-3</identifier.doi><identifier.scopus>eid_2-s2.0-77952237521</identifier.scopus><identifier.volume>28</identifier.volume><identifier.issue>3</identifier.issue><identifier.spage>361</identifier.spage><identifier.epage>361</identifier.epage><identifier.eissn>1573-0646</identifier.eissn><publisher.place>United States</publisher.place><description.other>Springer Open Choice, 01 Dec 2010</description.other><identifier.citeulike>6804307</identifier.citeulike><bitstream.url>http://hub.hku.hk/bitstream/10722/124033/1/ft.pdf</bitstream.url></item>

Author Affiliations

The University of Hong Kong
Prince of Wales Hospital Hong Kong
Chinese University of Hong Kong